Evidence map›Paper›PMID 28875497›Full record

ArticleJournal of the American Geriatrics Society2017

Cancer Screening of Older Adults in Israel According to Life Expectancy: Cross Sectional Study.

Ronen Bareket, Mara A Schonberg, Doron Comaneshter, Yochai Schonmann, Michal Shani, Arnon Cohen, Shlomo Vinker

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ronen BareketQuality Indicators and Research Department, Chief Physician Office, Clalit Health Services, Tel Aviv, Israel.
Mara A SchonbergDivision of General Medicine and Primary Care, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Doron ComaneshterQuality Indicators and Research Department, Chief Physician Office, Clalit Health Services, Tel Aviv, Israel.
Yochai SchonmannQuality Indicators and Research Department, Chief Physician Office, Clalit Health Services, Tel Aviv, Israel.
Michal ShaniQuality Indicators and Research Department, Chief Physician Office, Clalit Health Services, Tel Aviv, Israel.
Arnon CohenQuality Indicators and Research Department, Chief Physician Office, Clalit Health Services, Tel Aviv, Israel.
Shlomo VinkerDepartment of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Funding

Randomized Trial of a Mammography Decision Aid for Women Aged 75 and OlderR01CA181357 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHONBERG, MARA A · 2014 to 2018
$2.9M
Breast Cancer Risk Factors Among Women Aged 75 and OlderR01AG041869 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHONBERG, MARA A · 2013 to 2015
$1.4M
NCI NIH HHS R01 CA181357NIA NIH HHS R01 AG041869
6 · The paper itself

Abstract

objectivesTo examine over-screening of older Israelis for colon and breast cancer.

designCross sectional.

settingClalit Health Services (CHS), Israel's largest health maintenance organization (HMO), provides care for more than half of the country's population and operates a national age-based programs for cancer screening.

participantsAll community-dwelling members aged 65 to 79 in 2014 (N = 370,876). MEASUREMENTS: We used CHS data warehouse to evaluate cancer screening during 2014. Life expectancy (LE) was estimated using the validated Schonberg index.

resultsAlmost one-quarter (23.1%; 15.6% of adults aged 65-74, 42.7% of adults aged 75-79) of the study population had an estimated LE of less than 10 years. Annual fecal occult blood test and biannual mammography rates among adults aged 65 to 74 with a LE of 10 years or longer were 37.1% and 70.0%, respectively. Rates dropped after age 75 (4.0%, 19.5%) and to a lesser extent with a LE of less than 10 years (31.6%, 56.4%). Prostate-specific antigen testing is not part of the national screening program, and the proportion of people tested (42.6%), did not vary similarly with age of 75 and older (43.2%) or LE of less than 10 years (38.1%).

conclusionThe cancer screening inclusion criteria of the national referral system have a strong effect on receipt of screening; LE considerations are less influential. Some method of estimating LE could be incorporated into algorithms to improve individualized cancer screening to reduce over- and underscreening of older adults.

Indexed as

Life ExpectancyPatient PreferenceAgedAged, 80 and overBreast NeoplasmsColorectal NeoplasmsCross-Sectional StudiesDecision MakingFemaleHealth Services AccessibilityHumansIsraelMaleMass ScreeningNeoplasmsOutcome Assessment, Health Carecommunity health planningearly detection of cancerlife expectancymedical overuse

Identifiers

PMID28875497
PMCPMC5734912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.